Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
CASIN
Cat. No.:
OB0225LY-0046
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
CASIN is a potent Cdc42 inhibitor that perturbs Cdc42-mediated cellular processes.
Synonym:
Pirl1-related Compound 2; 425399-05-9; 2-[(6-Phenyl-2,3,4,9-tetrahydro-1H-carbazol-1-yl)amino]ethanol; 2-[(2,3,4,9-Tetrahydro-6-phenyl-1H-carbazol-1-yl)amino]ethanol
CAS No.:
425399-05-9
Compound CID:
2882155
Formula:
C20H22N2
Formula Weight:
306.4
Specification
Relative Density:
1.23 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
CASIN is commonly used to study cytoskeletal reorganization, cell migration and tumor metastasis models, providing an important tool for understanding cell behavior.
Library Information
Targets:
GTPase superfamily; CDK family
Receptors:
GTPase Cdc42; Ras; STAT3
Pathways:
JAK/STAT signaling; Cell cycle/Checkpoint; MAPK; GPCR/G protein; Stem cells
Plate Number:
AOCL-1
Plate Location:
e8
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
55 mg/mL; 179.5 mM
